Global HERG Screening Market Research Report—Forecast till 2027

Table of Contents

TABLE OF CONTENT 1 EXECUTIVE SUMMARY 1.1 MARKET SYNOPSIS 14 1.2 MARKET ATTRACTIVENESS ANALYSIS 15 2 MARKET INTRODUCTION 2.1 DEFINITION 16 2.2 SCOPE OF THE STUDY 16 2.3 RESEARCH OBJECTIVE 16 2.4 MARKET STRUCTURE 16 2.5 ASSUMPTIONS & LIMITATIONS 17 3 RESEARCH METHODOLOGY 3.1 DATA MINING 18 3.2 SECONDARY RESEARCH 19 3.3 PRIMARY RESEARCH 20 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 21 3.5 FORECASTING TECHNIQUES 21 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22 3.6.1 BOTTOM-UP APPROACH 23 3.6.2 TOP-DOWN APPROACH 23 3.7 DATA TRIANGULATION 24 3.8 VALIDATION 24 4 MARKET DYNAMICS 4.1 OVERVIEW 25 4.2 DRIVERS 26 4.2.1 INCREASING NOVEL DRUG APPROVALS 26 4.2.2 INCREASING PREVALENCE OF HEART DISEASES 26 4.3 RESTRAINT 27 4.3.1 HIGH COST OF HERG SCREENING PRODUCTS 27 4.4 OPPORTUNITY 28 4.4.1 UNTAPPED MARKETS 28 4.5 IMPACT OF CORONAVIRUS (COVID)-19 28 4.5.1 OVERVIEW 28 4.5.2 IMPACT ON PLAYERS 28 4.5.3 IMPACT ON CLINICAL TRIALS 28 5 MARKET FACTOR ANALYSIS 5.1 SUPPLY CHAIN ANALYSIS 29 5.1.1 R&D AND DESIGNING 29 5.1.2 MANUFACTURING 30 5.1.3 DISTRIBUTION 30 5.1.4 MARKETING & SALES 30 5.1.5 POST-SALES MONITORING 30 5.2 PORTER’S FIVE FORCES MODEL 30 5.2.1 BARGAINING POWER OF SUPPLIERS 31 5.2.2 BARGAINING POWER OF BUYERS 31 5.2.3 THREAT OF NEW ENTRANTS 32 5.2.4 THREAT OF SUBSTITUTES 32 5.2.5 RIVALRY 32 5.3 TECHNOLOGICAL TRENDS IN GLOBAL HERG SCREENING MARKET 32 5.3.1 INCREASING TREND OF OUTSOURCING HERG SERVICES 32 5.3.2 ADVENT OF PATCH CLAMP ASSAY 33 5.3.3 STRATEGIC INITIATIVES BY PLAYERS IN THE MARKET 33 5.4 CUSTOMER NEED ANALYSIS 33 5.4.1 OVERVIEW 33 5.4.2 CLINICAL TRIAL FOR HERG SCREENING 33 5.4.3 CAUSE AND EFFECT ANALYSIS 34 6 GLOBAL HERG SCREENING MARKET, BY TYPE 6.1 OVERVIEW 35 6.2 GENE KCNH2 36 6.3 MUTANT KCNH2 36 7 GLOBAL HERG SCREENING MARKET, BY ION CHANNEL 7.1 OVERVIEW 37 7.2 VOLTAGE-GATED ION CHANNEL 39 7.3 LIGAND-GATED ION CHANNEL 39 7.4 OTHERS 40 8 GLOBAL HERG SCREENING MARKET, BY APPLICATION 8.1 OVERVIEW 41 8.2 ANTIARRHYTHMIC 43 8.3 ANTIPSYCHOTIC 43 8.4 ANTIBIOTIC 43 8.5 OTHERS 44 9 GLOBAL HERG SCREENING MARKET, BY REGION 9.1 OVERVIEW 45 9.2 AMERICAS 47 9.2.1 NORTH AMERICA 49 9.2.1.1 US 51 9.2.1.2 CANADA 52 9.2.2 LATIN AMERICA 53 9.3 EUROPE 54 9.3.1 WESTERN EUROPE 56 9.3.1.1 GERMANY 58 9.3.1.2 FRANCE 59 9.3.1.3 UK 60 9.3.1.4 ITALY 61 9.3.1.5 SPAIN 62 9.3.1.6 REST OF WESTERN EUROPE 63 9.3.2 EASTERN EUROPE 64 9.4 ASIA-PACIFIC 65 9.4.1 CHINA 67 9.4.2 JAPAN 68 9.4.3 INDIA 69 9.4.4 AUSTRALIA 70 9.4.5 SOUTH KOREA 71 9.4.6 REST OF ASIA-PACIFIC 72 9.5 MIDDLE EAST & AFRICA 73 9.5.1 MIDDLE EAST 75 9.5.2 AFRICA 76 10 COMPETITIVE LANDSCAPE 10.1 OVERVIEW 77 10.2 MARKET RANKING ANALYSIS 77 10.3 COMPETITIVE BENCHMARKING 78 10.4 KEY DEVELOPMENTS AND GROWTH STRATEGIES 79 10.4.1 PARTNERSHIP 79 10.4.2 ACQUISITIONS 80 10.4.3 COLLABORATION 80 10.5 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 81 10.5.1 SALES & OPERATING PROFIT MARGIN 81 10.5.2 R&D EXPENDITURE 81 11 COMPANY PROFILES 11.1 THERMO FISHER SCIENTIFIC INC. 82 11.1.1 COMPANY OVERVIEW 82 11.1.2 FINANCIAL OVERVIEW 82 11.1.3 PRODUCTS/SERVICES OFFERED 83 11.1.4 KEY DEVELOPMENTS 83 11.1.5 SWOT ANALYSIS 83 11.1.6 KEY STRATEGIES 83 11.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 84 11.2.1 COMPANY OVERVIEW 84 11.2.2 FINANCIAL OVERVIEW 84 11.2.3 PRODUCTS/SERVICES OFFERED 85 11.2.4 KEY DEVELOPMENTS 85 11.2.5 SWOT ANALYSIS 86 11.2.6 KEY STRATEGIES 86 11.3 MERCK KGAA 87 11.3.1 COMPANY OVERVIEW 87 11.3.2 FINANCIAL OVERVIEW 87 11.3.3 PRODUCTS/SERVICES OFFERED 88 11.3.4 KEY DEVELOPMENTS 88 11.3.5 SWOT ANALYSIS 88 11.3.6 KEY STRATEGIES 88 11.4 EUROFINS DISCOVERX CORPORATION 89 11.4.1 COMPANY OVERVIEW 89 11.4.2 FINANCIAL OVERVIEW 89 11.4.3 PRODUCTS/SERVICES OFFERED 90 11.4.4 KEY DEVELOPMENTS 90 11.4.5 SWOT ANALYSIS 90 11.4.6 KEY STRATEGIES 91 11.5 ABCAM PLC. 92 11.5.1 COMPANY OVERVIEW 92 11.5.2 FINANCIAL OVERVIEW 92 11.5.3 PRODUCTS/SERVICES OFFERED 93 11.5.4 KEY DEVELOPMENTS 93 11.5.5 SWOT ANALYSIS 94 11.5.6 KEY STRATEGIES 94 11.6 CYPROTEX LIMITED 95 11.6.1 COMPANY OVERVIEW 95 11.6.2 FINANCIAL OVERVIEW 95 11.6.3 PRODUCTS/SERVICES OFFERED 95 11.6.4 KEY DEVELOPMENTS 95 11.6.5 SWOT ANALYSIS 96 11.6.6 KEY STRATEGIES 96 11.7 B‘SYS GMBH 97 11.7.1 COMPANY OVERVIEW 97 11.7.2 FINANCIAL OVERVIEW 97 11.7.3 PRODUCTS/SERVICES OFFERED 97 11.7.4 KEY DEVELOPMENTS 97 11.7.5 SWOT ANALYSIS 98 11.7.6 KEY STRATEGIES 98 11.8 CREATIVE BIOARRAY 99 11.8.1 COMPANY OVERVIEW 99 11.8.2 FINANCIAL OVERVIEW 99 11.8.3 PRODUCTS/SERVICES OFFERED 99 11.8.4 KEY DEVELOPMENTS 99 11.8.5 SWOT ANALYSIS 100 11.8.6 KEY STRATEGIES 100 11.9 METRION BIOSCIENCES LTD 101 11.9.1 COMPANY OVERVIEW 101 11.9.2 FINANCIAL OVERVIEW 101 11.9.3 PRODUCTS/SERVICES OFFERED 101 11.9.4 KEY DEVELOPMENTS 101 11.9.5 SWOT ANALYSIS 102 11.9.6 KEY STRATEGIES 102 11.10 AURORA BIOMED INC. 103 11.10.1 COMPANY OVERVIEW 103 11.10.2 FINANCIAL OVERVIEW 103 11.10.3 PRODUCTS/SERVICES OFFERED 103 11.10.4 KEY DEVELOPMENTS 103 11.10.5 SWOT ANALYSIS 104 11.10.6 KEY STRATEGIES 104 12 APPENDIX 12.1 REFERENCES 105 12.2 RELATED REPORTS 105